JP2007512256A5 - - Google Patents

Download PDF

Info

Publication number
JP2007512256A5
JP2007512256A5 JP2006540036A JP2006540036A JP2007512256A5 JP 2007512256 A5 JP2007512256 A5 JP 2007512256A5 JP 2006540036 A JP2006540036 A JP 2006540036A JP 2006540036 A JP2006540036 A JP 2006540036A JP 2007512256 A5 JP2007512256 A5 JP 2007512256A5
Authority
JP
Japan
Prior art keywords
group
alkyl
unsaturated
saturated
aromatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006540036A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007512256A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/038777 external-priority patent/WO2005049632A1/en
Publication of JP2007512256A publication Critical patent/JP2007512256A/ja
Publication of JP2007512256A5 publication Critical patent/JP2007512256A5/ja
Pending legal-status Critical Current

Links

JP2006540036A 2003-11-18 2004-11-18 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法 Pending JP2007512256A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52320703P 2003-11-18 2003-11-18
PCT/US2004/038777 WO2005049632A1 (en) 2003-11-18 2004-11-18 Bifunctional macrolide heterocyclic compounds and methods of making and using the same

Publications (2)

Publication Number Publication Date
JP2007512256A JP2007512256A (ja) 2007-05-17
JP2007512256A5 true JP2007512256A5 (https=) 2007-12-13

Family

ID=34619585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006540036A Pending JP2007512256A (ja) 2003-11-18 2004-11-18 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法

Country Status (4)

Country Link
US (1) US20070270357A1 (https=)
EP (1) EP1699808A1 (https=)
JP (1) JP2007512256A (https=)
WO (1) WO2005049632A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
JP5383037B2 (ja) * 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ,インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法
JP2009506063A (ja) 2005-08-24 2009-02-12 リブ−エックス ファーマシューティカルズ,インコーポレイテッド トリアゾール化合物ならびにこれを作製する方法および使用する方法
EP3290427A1 (en) 2005-08-24 2018-03-07 Melinta Therapeutics, Inc. Triazole compounds and methods of making and using the same
EP2657238A4 (en) 2010-12-24 2014-06-18 Univ Tohoku Macrolide compound having anticancer effect

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629232A (en) * 1969-08-19 1971-12-21 Abbott Lab 2'-o-alkanoyl-4'-alkanoyloxy derivatives of erythromycin
US3681325A (en) * 1970-09-30 1972-08-01 Abbott Lab De(n-methyl)-n-substituted derivatives of erythromycin
US4404201A (en) * 1981-11-13 1983-09-13 Warner-Lambert Company Cephalosporins
US4546176A (en) * 1982-12-14 1985-10-08 Eisai Co., Ltd. 7-Carboxymethoxyphenylacetamido-3-cephem derivatives and antibacterial preparations containing the same
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US6446032B1 (en) * 1990-09-21 2002-09-03 Massachusetts Institute Of Technology Designing compounds specifically inhibiting ribonucleic acid by binding to the minor groove
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
ES2101119T3 (es) * 1991-10-01 1997-07-01 Procter & Gamble Pharma Procedimiento para preparar quinolonil-lactamas antimicrobianas.
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
US5891643A (en) * 1995-11-14 1999-04-06 Abbott Laboratories Use of nuclear magnetic resonance to design ligands to target biomolecules
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
US6034069A (en) * 1997-09-30 2000-03-07 Abbott Laboratories 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US5955440A (en) * 1998-03-27 1999-09-21 Abbott Laboratories Macrolide LHRH antagonists
US6437119B1 (en) * 1998-05-07 2002-08-20 William Lawrence Truett Compounds formed from two or three antibiotics and their processes of preparation
WO1999063994A1 (en) * 1998-06-08 1999-12-16 Advanced Medicine, Inc. MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
US6420354B1 (en) * 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
EP1085845A2 (en) * 1998-06-08 2001-03-28 Advanced Medicine, Inc. Multibinding inhibitors of cyclooxygenase-2
US6541669B1 (en) * 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
WO1999063929A2 (en) * 1998-06-08 1999-12-16 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
US6020521A (en) * 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
US6479498B1 (en) * 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
EP1299109B1 (en) * 2000-04-27 2009-07-15 The Scripps Research Institute Bifunctional antibiotics
US20030158093A1 (en) * 2001-08-17 2003-08-21 Binyuan Sun Bifunctional glycopeptide antibiotics and combinatorial libararies thereof
US6576615B2 (en) * 2001-11-08 2003-06-10 Enanta Pharmaceuticals, Inc. 4′-O-substituted tylosin analogs
US6664240B2 (en) * 2001-11-15 2003-12-16 Enanta Pharmaceuticals, Inc. Tylosin derivatives having antibacterial activity
PL371335A1 (en) * 2002-01-22 2005-06-13 Pharmacia & Upjohn Company Infection-resistant medical devices
AU2003219770B2 (en) * 2002-02-15 2008-10-09 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
US6710034B2 (en) * 2002-04-19 2004-03-23 Enanta Pharmaceuticals, Inc. 5-O-mycaminosyltylonide derivatives
US6753415B2 (en) * 2002-04-19 2004-06-22 Enanta Pharmaceuticals, Inc. 23-O-substituted 5-O-mycaminosyltylonide derivatives
US7064110B2 (en) * 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
KR100661973B1 (ko) * 2002-05-13 2006-12-28 이난타 파마슈티칼스, 인코포레이티드 6,11 바이사이클릭 에리스로마이신 유도체
US7157433B2 (en) * 2002-07-08 2007-01-02 Glaxosmithkline Istrazivacki Centar Zagreb Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules
RU2330858C2 (ru) * 2002-07-08 2008-08-10 Глаксомитклайн Истраживацки Центар Загреб Д.О.О. Новые соединения, составы и способы лечения воспалительных заболеваний и состояний
PL374646A1 (en) * 2002-07-08 2005-10-31 Pliva-Istrazivacki Institutt D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
AR043050A1 (es) * 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
CN1780846A (zh) * 2003-03-05 2006-05-31 Rib-X医药品有限公司 双官能杂环化合物及其制备和使用方法
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same

Similar Documents

Publication Publication Date Title
RU2442778C9 (ru) Новые соединения, действующие как ингибиторы erk
RU2405774C9 (ru) Гетероциклические ингибиторы аспартилпротеазы
RU2481346C2 (ru) Ингибиторы фосфатидилинозитол-3-киназы
JP2010504346A5 (https=)
JP2007517846A5 (https=)
RU2013107007A (ru) Бифункциональные соединения, являющиеся ингибиторами rho-киназы, композиция и применение
JP2006505543A5 (https=)
SA519402422B1 (ar) مركبات 2-أريل غير متجانس-3-أكسو-2، 3-ثنائي هيدرو بيريدازين-4-كربوكساميد لمعالجة السرطان
EP1325921A3 (en) Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
JP2005526857A5 (https=)
JP2003519676A5 (https=)
CA2494049A1 (en) Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
UY28211A1 (es) Compuestos de hidroximetilo
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2010527913A5 (https=)
JP2002525329A5 (https=)
JP2007525520A5 (https=)
JPWO2020006264A5 (https=)
CA2539349A1 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
JP2007517007A5 (https=)
RU2009128970A (ru) Производные изосорбидмононитрата для лечения кишечных заболеваний
EA200701035A1 (ru) Замещенные n-сульфониламинобензил-2-феноксиацетамидные соединения
JP2007512256A5 (https=)
RU2008119994A (ru) Ингибиторы калиевых каналов
JP2010514734A5 (https=)